nafazatrom has been researched along with Purpura, Thrombotic Thrombocytopenic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Myatt, L; Williams, HJ; Young, KD | 1 |
Durrant, ST; Gordon-Smith, EC; Joosten, P | 1 |
Copplestone, JA; Hamblin, TJ; Sadullah, S; Worsley, A | 1 |
3 other study(ies) available for nafazatrom and Purpura, Thrombotic Thrombocytopenic
Article | Year |
---|---|
Thrombotic thrombocytopenic purpura: treatment with nafazatrom.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Epoprostenol; Female; Humans; Purpura, Thrombotic Thrombocytopenic; Pyrazoles; Pyrazolones | 1984 |
Nafazatrom in treatment of thrombotic thrombocytopenic purpura.
Topics: Adult; Drug Therapy, Combination; Epoprostenol; Female; Fibrinolytic Agents; Humans; Purpura, Thrombotic Thrombocytopenic; Pyrazoles; Pyrazolones | 1985 |
Nafazatrom in thrombocytopenic purpura.
Topics: Adult; Dipyridamole; Female; Humans; Plasma; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Pyrazoles; Pyrazolones; Recurrence | 1986 |